Aetion logo
Verified via Expert Interviews

Aetion: Revenue, Valuation & Competitors

Aetion company overview

Ownership
Acquired
Employees
275
Investors
-
Revenue / FTE
$2••k

About

Real-world evidence analytics platform for biopharmaceutical companies, payers, and regulators to generate evidence on treatment safety, effectiveness, and value.
Verified via Expert Interviews

Expert Vetted Data

Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former Aetion executives.

Ownership & Key Financials

Revenue

- '••
1

Investors

'25

Revenue / FTE

$2••k '••
1

Ownership

Acquired

FTEs

1
+15% CAGR
171
2020
249
2021
335
2022
312
2023
275
2024

Legal Disclaimer

The company profiles displayed here are abridged, indicative previews of the full, proprietary data available within the Dialectica Origin Platform, derived from confidential sources and expert-vetted research. This content is the exclusive Intellectual Property (IP) of Dialectica. Your access does not grant any rights to the data. Systematic copying, scraping, crawling, indexing, or extraction, whether by manual means, automated software, bots, or Large Language Models (LLMs), is strictly prohibited and violates our Terms of Use.

This information is provided 'as is' for promotional purposes only; Dialectica disclaims all liability for its accuracy, completeness, or any reliance placed upon it.